You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Unpacking the next battle in the never-ending war over Aduhelm
The next battle in the never-ending war over Aduhelm
Biogen and Eli Lilly have seriously hinted they plan to sue Medicare over its restrictions on the Alzheimer's drug Aduhelm.